Eikon Therapeutics, Inc. (EIKN)
9.21
-1.52
(-14.17%)
USD |
NASDAQ |
Sep 10, 16:00
9.12
-0.09
(-0.98%)
After-Hours: 05:35
Eikon Therapeutics Total Liabilities (Quarterly) : 313.07M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 313.07M |
| March 31, 2026 | 300.16M |
| December 31, 2025 | 312.30M |
| Date | Value |
|---|---|
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | 254.95M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 779.57M |
| Shareholders Equity (Quarterly) | 466.50M |
| Debt to Equity Ratio | 0.5407 |
| Current Ratio | 9.892 |
| Net Debt Paydown Yield | -1.41% |